• poster exhibition

    poster exhibition

  • The State Key Laboratory of Brain and Cognitive Sciences

    The State Key Laboratory of Brain and Cognitive Sciences

    A national platform in brain research

  • The State Key Laboratory of Brain and Cognitive Sciences

    The State Key Laboratory of Brain and Cognitive Sciences

    A national lab to conduct first rate, cutting-edge research in brain and cognitive sciences in the world

 
State Key Laboratory of Brain and Cognitive Sciences Research Seminars

 
 
Molecular Imaging for Dementia

Professor YEN Tzu-Chen

Professor, School of Medicine, Chang Gung Memorial Hospital, Taiwan

Co-hosted by
Department of Diagnostic Radiology,
Partner State Key Laboratory of Brain & Cognitive Sciences, &
Strategic Research Theme on Neuroscience, HKU
 

25 May 2017 (Thu)  9:15am Seminar Room 2, G/F

The Hong Kong Jockey Club Building for Interdisciplinary Research, 5 Sassoon Road, Pokfulam, Hong Kong
 

Abstract of the talk - 

      Recent advanced in imaging technology has provided medical expertise with a new window into the living human brain. These advances include both improvements in image resolution and the development of novel imaging biomarkers from single photon emission tomography, positron emission tomography, to magnetic resonance imaging. This revolution in neuroimaging tools have been developed and applied to neuropsychiatric disorders in order to understand further the neuroanatomical and neurophysiological bases of neurodegenerative illnesses and cognitive disorders, including Alzheimer’s disease. 

      This section reviews important new findings about the role of brain abnormalities in neurodegenerative disorders based on new imaging technology. There has been a shift from the study of brain regions implicated in neurodegenerative disorders to understanding the pathologic basis of clinical symptoms of dementia. This will likely facilitate the diagnostic reclassification, and enhance our understanding of the pathophysiological causes of these complex heterogeneous disorders. This review will also cover the current status of the relationship between dementia using novel image biomarker for amyloid and Tau protein.‚Äč

 ALL ARE WELCOME

TOP